I guess we'll know more about that soon. Avita have conducted a pilot trial for the use of Regenercell in treating venous leg ulcers. From today's AGM:
Results of Randomized, Multi-Center VLU Pilot Study Expected in Q4-2015
Rev
TIS Price at posting:
4.1¢ Sentiment: Hold Disclosure: Not Held